Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Advanced Lung Cancer
Related studies linked through entity extraction aliases.
CAR-T Cell Immunotherapy for Advanced Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- PHASE2
Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Cambridge Brain Mets Trial 1
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
- Status
- TERMINATED
- Phase
- PHASE2
Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
- Status
- COMPLETED
- Phase
- PHASE1